Hana Biosciences, Inc. Non-Employee Director Compensation Arrangements (Effective April 18, 2007)

Contract Categories: Human Resources › Compensation Agreements
Summary

Hana Biosciences, Inc. has established compensation arrangements for its non-employee directors. The non-executive Chair receives an annual cash retainer of $50,000 and $4,000 per meeting, while other non-employee directors receive $20,000 annually and $2,500 per meeting. Both the Chair and other non-employee directors are granted annual stock options, which vest after one year or immediately upon a change of control. Additionally, the Chair of the Audit Committee receives an annual restricted stock grant that also vests after one year. Employee directors are not eligible for these payments.

Read More Arrow
EX-10.1 2 v074046_ex10-1.htm
Exhibit 10.1


 
HANA BIOSCIENCES, INC.
NON-EMPLOYEE DIRECTOR
COMPENSATION ARRANGEMENTS
(Effective April 18, 2007)
 
 

 
The following is a summary of the compensation arrangements for directors of Hana Biosciences, Inc. (the “Company”) who are not employees of the Company. Directors who are employees of the Company do not receive compensation for their service on the Board and shall receive compensation only in their capacities as employees. The cash compensation arrangements are as follows:
 
1.
The non-executive Chair of the Board is entitled to receive an annual cash retainer of $50,000, plus a per meeting fee of $4,000.
 
2.
Each non-employee director (other than the Chair) is entitled to receive an annual retainer fee of $20,000, plus a per meeting fee of $2,500.
 
3.
The non-Executive Chair of the Board and each other non-employee director is also entitled to an annual stock option to purchase 75,000 and 40,000 shares of the Company’s common stock, respectively, which options would vest upon the first anniversary of the grant and would accelerate upon a change of control of the Company.

4.
The Chair of the Audit Committee of the Board is entitled to receive, in addition to his or her other Board compensation, an annual restricted stock grant of 10,000 shares, which would vest on the first anniversary of the grant.